Replies to post #1461 on Idera Pharmaceuticals Inc (IDRA)

[binchey]

DLBCL trial update 04/15 (very key event in Q1)
Update on GSO targets 05/15 (just a strategic view of IDRA)
IMO 9200 trials partnership deals 08/15 (hoping to see !)
Full data for WM 09/15 (partial data this week!)
GSO kick-offs, clinical trials 10/15 (should add a few bucks!)
Rare diseases Duchenne Dermatomyositis clinical updates 04/16
DLBCL full data 05/16
New indications on rare diseases 06/16
FDA break through application for WM and DLBCL 08/16
Accelerated approvals followed by sales on both WM and DLBCL 03/17